Cited by 190Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Comparing Guanfacine and Dextroamphetamine for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder

Taylor, Fletcher B., Russo, Joan·2001·Journal of Clinical Psychopharmacology

DOI 10.1097/00004714-200104000-00015

Open this paper in CoChat — free account

Abstract

The objective of this study was to compare the efficacy of the alpha-2a agonist guanfacine with that of dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder (ADHD). Seventeen adult outpatients who met DSM-IV criteria for ADHD participated in a double-blind, placebo-controlled, crossover study comparing drug effects on ADHD symptoms. Measures of change included the DSM-IV ADHD Behavior Checklist for Adults and the Copeland Symptom Checklist for Adult Attention Deficit Disorders. Cognitive measures of attention included the Stroop and Controlled Oral Word Association Test using the letters "C," "F," and "L" (COWAT, CFL version). For each trial, the drug was administered daily and titered up to optimal doses of maximum efficacy but with a minimum of side effects, and then data were collected. Both drugs significantly reduced ADHD symptoms on the DSM-IV Adult Behavior Checklist for Adults over placebo (p < 0.05). The Stroop Color subscale showed significant improvement for both drugs (p < 0.05), but the Color-Word measures showed significant improvement for guanfacine only (p < 0.01). The average dose of guanfacine was 1.10 (SD = 0.60), and the most common side effect of guanfacine was fatigue. No subjects discontinued drug trials. This preliminary study indicates that guanfacine may be a well-tolerated treatment option for adult ADHD.

Integrity signals

Registry

Crossref · 10.1097/00004714-200104000-00015

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
Role of locus coeruleus in attention and behavioral flexibility
Aston-Jones, G., Rajkowski, J., & Cohen, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00140-7 · Cited by 900
Regional and cellular fractionation of working memory
Goldman‐Rakic, P. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13473 · Cited by 826
Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine
Kuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623
Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder
Biederman, J., & Spencer, T. J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00192-4 · Cited by 515
The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder
Arnsten, A. F. T. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050084013 · Cited by 458
Multiple Ionic Conductances of the Human Dopamine Transporter: The Actions of Dopamine and Psychostimulants
Sonders, M. S., Zhu, S.-J., Zahniser, N. R., Kavanaugh, M. P., & Amara, S. G. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00960.1997 · Cited by 446
Neurobiology of Attention Deficit Disorder With Hyperactivity: Where Have We Come in 50 Years?
Zametkin, A. J., & Rapoport, J. L. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198709000-00011 · Cited by 348

Show all 25 references

Research works printed but not linked: 2

Murphy, 1996, ADHD Rep, 4, 12
Holdnack, 1995, Neuropsychiatry Neuropsychol Behav Neurol, 8, 282

Sorted by citations

Items 101–190 of 190

Guanfacine treatment for prefrontal cognitive dysfunction in older participants: A randomized clinical trial
Barcelos, N. M., Van Ness, P. H., Wagner, A. F., MacAvoy, M. G., Mecca, A. P., Anderson, G. M., Trentalange, M., Hawkins, K. A., Sano, M., Arnsten, A. F. T., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.05.033 · Cited by 21
Unlocking the potential of patients with ADHD: A model for clinical practice.
Monastra, V. J. (2008) · American Psychological Association eBooks · doi:10.1037/11665-000 · Cited by 21
Drug Class Review on Pharmacologic Treatments for ADHD
McDonagh, M. S., Peterson, K., & Thakurta, S. (2005) · Cited by 21
Pre- versus Postsynaptic Signaling by α2-Adrenoceptors
Gilsbach, R., Albarrán-Juárez, J., & Hein, L. (2011) · Current topics in membranes · doi:10.1016/b978-0-12-384921-2.00007-0 · Cited by 19
The effects of guanfacine on working memory performance in patients with localization-related epilepsy and healthy controls
Swartz, B. E., McDonald, C. R., Patel, A., & Torgersen, D. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181633461 · Cited by 20
Elements toward novel therapeutic targeting of the adrenergic system
Ghanemi, A., & Hu, X. (2014) · Neuropeptides · doi:10.1016/j.npep.2014.11.003 · Cited by 19
Evaluation of histopathologic and histomorphometric changes of testicular tissue and gonadotropin levels following consumption of methylphenidate in male mice
Fazelipour, S., Tootian, Z., Saremi, Z., Shafii, M., Sheibani, M. T., Kiaei, S. B., KIUMARSI, M., & Asadi, F. (2014) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1301-109 · Cited by 19
ADHD with Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical and Pharmacological Aspects Across the Lifespan
Mucci, F., Avella, M. T., & Marazziti, D. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190805153610 · Cited by 21
Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years
Kisicki, J. C., Fiske, K. S., & LYNE, A. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.020 · Cited by 18
Guanfacine Treatment of Clozapine-Induced Sialorrhea
Webber, M. A., Szwast, S. J., Steadman, T. M., Frazer, A., Malloy, F. W., Lightfoot, J. D., & Shekhar, A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000145348.06783.1d · Cited by 18
Zur Wirksamkeit pharmakologischer und psychotherapeutischer Therapien bei Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter: Eine empirische Metaanalyse
Linderkamp, F., & Lauth, G. W. (2011) · Verhaltenstherapie · doi:10.1159/000332429 · Cited by 18
The Pathophysiology, Medical Management, and Dental Implications of Children and Young Adults Having Attention-Deficit Hyperactivity Disorder
Friedlander, A. H., Yagiela, J. A., Paterno, V. I., & Mahler, M. E. (2003) · Journal of the California Dental Association · doi:10.1080/19424396.2003.12224214 · Cited by 17
Pharmacotherapy of adult attention deficit/hyperactivity disorder: review of evidence-based practices and future directions
Tcheremissine, O. V., & Salazar, J. O. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.8.1299 · Cited by 17
Chapter 12 The dysexecutive syndromes
Daffner, K. R., & Searl, M. M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)88012-2 · Cited by 15
Treatment of attention deficit hyperactivity disorder in adults
Greenfield, B., & Hechman, L. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.1.107 · Cited by 16
South Korean geriatrics on Beers Criteria medications at risk of adverse drug events
Kim, G. J., Lee, K. H., & Kim, J. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191376 · Cited by 13
Lifetime evolution of ADHD treatment
Mucci, F., Carpita, B., Pagni, G., Vecchia, A. D., Bjedov, S., Pozza, A., & Marazziti, D. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02336-w · Cited by 15
The Neurobiological Basis of Attention-Deficit/Hyperactivity Disorder
Arnsten, A. F. T., Berridge, C. W., & McCracken, J. T. (2009) · Primary psychiatry · Cited by 14
Stimulants
Childress, A. C. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.03.001 · Cited by 15
Current issues and trends in the diagnosis and treatment of adults with ADHD
Cumyn, L., Kolar, D., Keller, A., & Hechtman, L. T. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.10.1375 · Cited by 13
Trends in the prescribing of stimulant medication for the treatment of Attention Deficit Hyperactivity Disorder in adults in NSW
Salmelainen, P. (1900) · New South Wales Public Health Bulletin Supplementary Series · doi:10.1071/nb04s30 · Cited by 13
Pharmacological treatment of attention-deficit/hyperactivity disorder in adults
Slatkoff, J., & Greenfield, B. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.6.649 · Cited by 15
Efficacy of Stimulants in Adult ADHD
Maidment, I. (2003) · The Annals of Pharmacotherapy · doi:10.1345/aph.1d028 · Cited by 13
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder
Brancati, G. E., Magnesa, A., Acierno, D., Carli, M., Rosa, U. D., Froli, A., Gemignani, S., Ventura, L., Weiss, F., & Perugi, G. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2370346 · Cited by 16
A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression
Hack, L. M., Jubeir, J., Hilton, R. A., Tozzi, L., Boyar, L., Zhang, X., Lyons, T., Jo, B., O'Hara, R. M., Schatzberg, A. F., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00510-7 · Cited by 11
Pharmacotherapy of ADHD in adults
Prince, J. B., Morrison, N. R., & Wilens, T. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.023 · Cited by 11
Monoaminergic‐based Pharmacotherapy for Depression
Papakostas, G. I., & D, M. F. M. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch6 · Cited by 11
Long-Term Impact of Diffuse Traumatic Brain Injury on Neuroinflammation and Catecholaminergic Signaling: Potential Relevance for Parkinson’s Disease Risk
Wee, I. C., Arulsamy, A., Corrigan, F., & Collins‐Praino, L. E. (2024) · Molecules · doi:10.3390/molecules29071470 · Cited by 10
Sex differences in noradrenergic modulation of attention and impulsivity in rats
Mei, X., Wang, L., Yang, B., & Li, X. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05841-8 · Cited by 12
Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacine
Collaço, R. D. C., Lammens, M., Blevins, C., Rodgers, K., Gurau, A., Yamauchi, S., Kim, C. G., Forrester, J., Liu, E., Ha, J. S., et al. (2023) · Clinical Autonomic Research · doi:10.1007/s10286-023-01004-1 · Cited by 9
Emerging drugs for attention-deficit/hyperactivity disorder
Weisler, R. H. (2007) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.12.3.423 · Cited by 9
The Roles of Norepinephrine and Serotonin in Attention Deficit Hyperactivity Disorder
Oades, R. D. (2005) · Contemporary clinical neuroscience · doi:10.1385/1-59259-891-9:097 · Cited by 9
Attention-Deficit/Hyperactivity Disorder: Diagnosis and Treatment
REIFF, M. I., & Stein, M. T. (2004) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00043-9 · Cited by 8
Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
McDonagh, M. S., & Peterson, K. (2011) · Cited by 7
Treatment of Adult ADHD without Stimulants: Effectiveness in A Dually Diagnosed Correctional Population
Bastiaens, L., Scott, O., & Galus, J. (2018) · Psychiatric Quarterly · doi:10.1007/s11126-018-9602-7 · Cited by 7
College students with ADHD
Ramsay, J. R., & Rostain, A. L. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.030 · Cited by 6
Non-Stimulant Trials of Adult ADHD
Adler, L. A. (2007) · CNS Spectrums · doi:10.1017/s109285290002602x · Cited by 4
Do adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder?
Hazell, P. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.12.1989 · Cited by 4
Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments
Stanford, S. C., & Heal, D. J. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_675 · Cited by 3
The Treatment of Adult ADHD: Complexity at Hand
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_19 · Cited by 3
Impact of a Step Therapy for Guanfacine Extended-Release on Medication Utilization and Health Care Expenditures Among Individuals Receiving Treatment for ADHD
Suehs, B. T., Sikirica, V., Mudumby, P., Dufour, R., & Patel, N. C. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.9.793 · Cited by 3
Attention Deficit Hyperactivity Disorder: Pathophysiology and Design of New Treatments
Glase, S. A., & Dooley, D. J. (2004) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(04)39001-9 · Cited by 3
New Directions in the Treatment of Comorbid Attention Deficit Hyperactivity Disorder and Tourette’s Syndrome
Palumbo, D. R. (2004) · Neurological disease and therapy · doi:10.1201/b14236-6 · Cited by 3
Pharmacological Treatments for ADHD and the Novel Agent Atomoxetine
Bailey, K. P. (2003) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/0279-3695-20030801-09 · Cited by 3
Non-stimulant Drug Treatments for Adults with ADHD
Coghill, D. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-248-3_6 · Cited by 1
Treatment
Kooij, J. J. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82812-7_4 · Cited by 2
New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder in Primary Care
(2006) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v08n0406 · Cited by 2
Pain Comorbidities with Attention Deficit: A Narrative Review of Clinical and Preclinical Research
Liang, H.-B., He, W., Liu, Y., & Wang, H. (2024) · Journal of Pain Research · doi:10.2147/jpr.s443915 · Cited by 4
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung ADHS) im Erwachsenenalter
Alm, B., & Sobanski, E. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_64 · Cited by 2
A META-ANALYSIS OF PRESCRIPTION STIMULANT EFFICACY: ARE STIMULANTS NEUROCOGNITIVE ENHANCERS?
Marraccini, M. E. (2015) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-marraccini-marisa-2015 · Cited by 2
To Prescribe or Not? Pharmacological Options in Adult Attention-Deficit/Hyperactivity Disorder
Aoshima-Kilroy, A., Banu, S., Udoetuk, S., Shah, A. A., & Moukaddam, N. (2017) · Psychiatric Annals · doi:10.3928/00485713-20170510-01 · Cited by 1
Review of Clinical Considerations in the Management of Adolescents with ADHD During Ramadan
Khan, F., & Mohiuddin, S. S. (2024) · Adolescent Psychiatry · doi:10.2174/0122106766298494240510052101 · Cited by 1
Pharmacological Agents for the Treatment of Adult Attention Deficit Hyperactivity Disorder: A Review of the Literature
Sherwood, D. A., & Rey, J. A. (2006) · Journal of Pharmacy Practice · doi:10.1177/0897190007300727 · Cited by 1
Once-daily medications for the pharmacological management of ADHD in adults
Tcheremissine, O. V. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s4206 · Cited by 1
Attention Deficit Hyperactivity Disorder Through The Life Cycle
Rostain, A. L. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.3.266 · Cited by 1
Managing attentional disorders
Palumbo, D. R., & Diehl, J. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545894.013 · Cited by 1
Treatment
Kooij, J. J. S. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4138-9_4 · Cited by 1
ADHD
Carpentier, P. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_22 · Cited by 1
Patient Responses to Guanfacine in Cocaine Addiction
Milivojevic, V., Sinha, R., & Fox, H. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803750-8.00069-5 · Cited by 1
ADHD and Co-Occurring Substance Use Disorders
Hernández, M., Dambreville, N., & LEVIN, F. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-84834-7_2 · Cited by 1
TDAH en adultos factores genéticos, evaluación y tratamiento farmacológico
Ramos‐Quiroga, J. A. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
New Directions in the Treatment of Comorbid Attention Deﬁcit Hyperactivity Disorder and Tourette’s Syndrome
Palumbo, D. R. (2004) · CRC Press eBooks · doi:10.3109/9780203996966-8 · Cited by 1
Differential effects of a single dose of Lisdexamfetamine and Guanfacine on cognitive function in children with ADHD
El Masri, S., Kowalczyk, O. S., Chiu, T. H., Criaud, M., Lukito, S., Mazibuko, N., Salazar de Pablo, G., Perez Rodriguez, V., Makos, O., Lam, S.-L., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1676472
The use of nonstimulant drugs in the treatment of adult ADHD
Wim, J., Verbeeck, C., & Tuinier, S. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511780752.019
Interaction of Methylphenidate and External Cue in an ADHD Behavioral Training Model
Kimmick, E., McGovern, R. W., & Gittis, A. G. (2012) · Journal of Student Research · doi:10.47611/jsr.v1i2.83
Molecular Pharmacology and the Treatment of Tourette's Syndrome and Attention Deficit-Hyperactivity Disorder
Arnsten, A. F. T. (2005) · Elsevier eBooks · doi:10.1016/b978-012738903-5/50012-6
Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder
Rostain, A. L. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0063-4
THE ROLE OF ALTERED CATECHOLAMINERGIC ACTIVITY IN THE ATTENTIONAL DYSFUNCTION INDUCED BY LEAD EXPOSURE OR PRENATAL COCAINE EXPOSURE
Bayer, L. E. (2008) · eCommons (Cornell University)
Is Guanfacine as Good as Amphetamine for Adult ADHD
Roy‐Byrne, P. (2001) · Journal watch · doi:10.1056/jp200105080000002
Évaluation préliminaire de l’efficacité de la duloxétine dans le déficit de l’attention chez l’adulte : essai randomisé contrôlé
Bilodeau, M. (2012) · doi:10.71781/30427
Medications Used in the Treatment of Attention Disorders
(2013) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814343664_0016
Congenital, developmental, and other childhood-onset disorders
Omachonu, V. K., & Ross, J. E. (2012) · CRC Press eBooks · doi:10.1201/b13258-16
Current Awareness
(2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.276
Medications Affecting Behavior and Learning
Goldstein, S., Naglieri, J. A., & DeVries, M. L. (2011) · Wiley eBooks · doi:10.1002/9781118093085.ch18
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter
Alm, B., & Sobanski, E. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_73
Guanfacine for adult ADHD: preliminary results promising
&NA; (2001) · Inpharma Weekly · doi:10.2165/00128413-200112900-00034
6. References
Ablashi, D., Armstrong, G., & Manaker, U. (1900) · New South Wales Public Health Bulletin Supplementary Series · doi:10.1071/nb04s38
Stimulant Medications
Childress, A. C. (2015) · The Encyclopedia of Clinical Psychology · doi:10.1002/9781118625392.wbecp268
Congenital, developmental and other childhood-onset disorders
(2008) · CRC Press eBooks · doi:10.1201/b13308-13
Attention Deficit/Hyperactivity Disorder and Substance Abuse
Levin, F. (2015) · Springer eBooks · doi:10.1007/978-88-470-5322-9_119
Does Dexamphetamine Cause Addiction? A Narrative Review
Khalifa, H., Hibbert, E., Gauci, N., & Poulton, A. S. (2025) · Psychoactives · doi:10.3390/psychoactives4010003
Transtorno do déficit de atenção e hiperatividade na fase adulta: um estudo sobre fatores de persistência e estratégias terapêuticas
Hilário, B. D. L., Ribeiro, C. R. F., & Llausas, R. V. (2025) · RCMOS - Revista Científica Multidisciplinar O Saber · doi:10.51473/rcmos.v1i2.2025.1368
PHARMACOLOGICAL TREATMENT STRATEGIES FOR ADHD: A SYSTEMATIC REVIEW
Grzesikowski, P., Klich, P., Bekier, K., Kubiak, J., Górski, J., Nowicka, H., Liszka, D., Joks, M. M., Ordon, E., & Ostromecka, K. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3814 · Cited by 1
Effets de l'exposition prénatale au MDMA (« Ecstasy ») ou au méthylphénidate sur les systèmes dopaminergiques chez le rat adulte
Heuland, E. (2009) · theses.fr (ABES) · doi:10.70675/6fc98b80z890ez4f4ezaa80z3fe7e1b32389
Cortical mechanisms of comorbidity between pain sensitization and attention-deficit/hyperactivity disorder (ADHD) in a mouse model
Nehme, S. B. S. (2024) · theses.fr (ABES) · doi:10.70675/7ad70482z0961z4eebzbc86z84355cab1f1d
Cognitive Dysfunction and Suicide
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_19
Clinical Outcomes of Extended-Release Guanfacine in Adults With Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review
Suzuki, H., Hayashi, W., Nakamura, D., Seki, S., Hanawa, Y., Yamauchi, M., Nakamura, Y., Sugita, S., Sanada, K., & Iwanami, A. (2026) · Cureus · doi:10.7759/cureus.110044
Chapter 7. Stimulants
Ziffra, M. S. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551913.lg07
GUANFACINE IN THE TREATMENT OF ATTENTION – DEFICIT/HYPERACTIVITY DISORDER: MECHANISMS, CLINICAL EVIDENCE AND THERAPEUTIC IMPLICATIONS
Kita, N., Broniszewska, P., Kamrowska, M., Swiech, J., Kopacki, F., Apanasewicz, K., Szczeblewska, W., Jaskot, D., Marzec, J., & Sztenc, N. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5501
The Influence of ADHD Dimensions on Anxiety and Depressive Symptoms on Adults: A Cross-Sectional Study
Sabrin, M. R. R., Kumarpillai, G., Mahmood, N., Shankar, R. U., Nandavar, S., Sumantha, Y. J., & Pallerla, S. (2026) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_112_26

Authors: Taylor, F. B., & Russo, J.
Affiliations: University of Washington (US)
Corresponding author: Taylor, Fletcher B.
Venue: Journal of Clinical Psychopharmacology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2001-04
Volume: 21
Issue: 2
Pages: 223-228
ISSN: 0271-0749 (ISSN-L)
DOI: 10.1097/00004714-200104000-00015
OpenAlex: W2018897037
Cited by: 189
References: 25
Citations by year: 2026: 4 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 1 · 2015: 5 · 2014: 10 · 2013: 5 · 2012: 11
FWCI: 6.66
Type: journal article
Language: en
Open access: closed
Locations: Journal of Clinical Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords: adult ADHD, guanfacine, d-amphetamine, stimulant medication, ADHD symptom reduction, Stroop task, Controlled Oral Word Association Test, attention, drug tolerability, fatigue
MeSH terms: Adrenergic alpha-Agonists, Adult, Analysis of Variance, Attention Deficit Disorder with Hyperactivity, Dextroamphetamine, Double-Blind Method, Female, Humans, Male, Middle Aged, Psychological Tests, Guanfacine, Cross-Over Studies, Adrenergic Uptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Comparing Guanfacine and Dextroamphetamine for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks